Ng, Hooi Hooi
- Postdoctoral Associate, Biomedical Engineering , College of Engineering and Computing
Scholarly & Creative Works
selected publications
-
Article
-
2022The Time-Dependent Role of Bisphosphonates on Atherosclerotic Plaque CalcificationFull Text via DOI: 10.3390/jcdd9060168 Web of Science: 000816404400001
-
2022S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in MiceFull Text via DOI: 10.3389/fcvm.2022.809301 Web of Science: 000807820700001
-
2019Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosisFull Text via DOI: 10.1096/fj.201901046R Web of Science: 000507461600065
-
2019Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insightsFull Text via DOI: 10.1111/bph.14858 Web of Science: 000493438200001
-
2019Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathwaysFull Text via DOI: 10.1016/j.mce.2019.01.015 Web of Science: 000463350300010
-
2019Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compoundsFull Text via DOI: 10.1016/j.mce.2018.12.013 Web of Science: 000463350300007
-
2019Recent developments in relaxin mimetics as therapeutics for cardiovascular diseasesFull Text via DOI: 10.1016/j.coph.2019.04.001 Web of Science: 000483006200007
-
-
Book Chapter
-
2020Calcifying Extracellular Vesicles: Biology, Characterization, and Mineral Formation. 97-116.Full Text via DOI: 10.1007/978-3-030-46725-8_5
-
-
Conference
-
2020Therapeutic Effects of a Small Molecule Agonist of the Relaxin Receptor in Mice with Unilateral Ureteral ObstructionFull Text via DOI: 10.1096/fasebj.2020.34.s1.09260 Web of Science: 000546107900377
-
-
Other Scholarly Work
-
Preprint
-
Review
-
2018Relaxin as a Therapeutic Target for the Cardiovascular Complications of DiabetesFull Text via DOI: 10.3389/fphar.2018.00501 Web of Science: 000432304100001
-
2017Vascular actions of relaxin: nitric oxide and beyond. 1002-1014.Full Text via DOI: 10.1111/bph.13614
-
2016Serelaxin: A Novel Therapeutic for Vascular Diseases. 498-507.Full Text via DOI: 10.1016/j.tips.2016.04.001
-
Research
principal investigator on
- Targeting the oxidative signaling pathway in vascular calcification awarded by Florida Heart Research Foundation Inc 2021 - 2022
- Small Molecule Agonist of the Human Relaxin Receptor for Treatment of Vascular Calcification awarded by FIU Foundation 2020 - 2021
- Targeting relaxin receptor for the treatment of diabetes-induced cardiovascular calcification awarded by American Heart Association 2019 - 2020
Identifiers
ORCID iD
- https://orcid.org/0000-0002-2370-0849 (confirmed)
visualizations
publication subject areas
Citation index-derived subject areas the researcher has published in